We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

224 hedge funds and large institutions have $2.68B invested in Amicus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 86 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 26

65% more call options, than puts

Call options by funds: $9.49M | Put options by funds: $5.74M

51% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 57

22% more capital invested

Capital invested by funds: $2.2B → $2.68B (+$482M)

9% more funds holding

Funds holding: 205 → 224 (+19)

0.35% more ownership

Funds ownership: 107.63% → 107.98% (+0.35%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
4.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
50
Increased
86
Reduced
57
Closed
26
Calls
$9.49M
Puts
$5.74M
Net Calls
+$3.74M
Net Calls Change
-$1.35M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$27.4M
2
RG
Redmile Group
California
+$22.2M
3
Morgan Stanley
Morgan Stanley
New York
+$18.8M
4
N
Nuveen
North Carolina
+$18.3M
5
HRCM
Hood River Capital Management
Florida
+$11.7M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$36.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$24.9M
3
MWNA
Marshall Wace North America
New York
-$16.9M
4
EAM
Eventide Asset Management
Massachusetts
-$15.6M
5
Bank of America
Bank of America
North Carolina
-$13.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
26
Boxer Capital
California
$22.6M – – –
NHAS
27
Novo Holdings A/S
Denmark
$22.6M – – –
Primecap Management
28
Primecap Management
California
$22.4M +$893K +97,500 +4%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$22M +$721K +78,720 +4%
RCAMU
30
Rothschild & Co Asset Management US
Connecticut
$21.4M +$6.25M +682,567 +45%
BNP Paribas Asset Management
31
BNP Paribas Asset Management
France
$20.6M +$4.17M +455,637 +27%
SAM
32
Sectoral Asset Management
Quebec, Canada
$20.1M -$12.7M -1,381,961 -40%
CTA
33
Carillon Tower Advisers
Florida
$18.1M – – –
Fidelity Investments
34
Fidelity Investments
Massachusetts
$17.8M -$8.96M -978,347 -35%
Millennium Management
35
Millennium Management
New York
$17.7M +$4.44M +485,220 +37%
Charles Schwab
36
Charles Schwab
California
$16.1M +$981K +107,210 +7%
Deutsche Bank
37
Deutsche Bank
Germany
$15.9M -$36.7M -4,007,053 -71%
Massachusetts Financial Services
38
Massachusetts Financial Services
Massachusetts
$15.2M +$1.56M +170,062 +12%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$14.6M -$7.16M -782,365 -34%
PF
40
Phoenix Financial
Israel
$14.5M +$3.04M +332,310 +28%
Axa
41
Axa
France
$14.4M +$159K +17,398 +1%
CCM
42
Cadian Capital Management
New York
$13.5M +$3.56M +389,344 +39%
Franklin Resources
43
Franklin Resources
California
$13.5M -$12.3M -1,345,602 -49%
HRCM
44
Hood River Capital Management
Florida
$12.5M +$11.7M +1,281,553 New
PCM
45
Peregrine Capital Management
Minnesota
$12.2M +$11.5M +1,255,580 New
GTC
46
Ghost Tree Capital
New York
$12.2M -$4.17M -455,000 -27%
RSCM
47
Rock Springs Capital Management
Maryland
$9.74M – – –
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$9.19M +$768K +83,870 +10%
CS
49
Candriam SCA
Luxembourg
$9.05M -$426K -46,500 -5%
ECP
50
Elk Creek Partners
Colorado
$8.37M -$1.2M -131,499 -13%
1
2
3 4 5

FOLD Hedge Fund Activity: Q4 2019 in Review

224 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2019, worth a combined $2.68B — up 22% from $2.2B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new FOLD positions and 26 closed out — a net gain of 24 holders — while 86 added to existing stakes and 57 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $27.4M. The largest seller was Deutsche Bank, cutting an estimated $36.7M.

  • 224 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2019, up from 205 in Q3 2019.
  • Funds reported $2.68B of Amicus Therapeutics stock for Q4 2019, up 22% quarter-over-quarter.
  • 50 funds opened new Amicus Therapeutics positions in Q4 2019 and 26 closed out, a net change of +24 holders.
  • The largest Amicus Therapeutics buyer in Q4 2019 was JP Morgan Chase, an estimated $27.4M added.
  • The largest Amicus Therapeutics seller in Q4 2019 was Deutsche Bank, an estimated $36.7M sold.

Based on aggregated 13F filings for Q4 2019.